Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Seibyl

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
European Journal of Neurology|December 5, 2002
Do dopamine agonists or levodopa modify Parkinson's disease progression?K Marek, D Jennings, J Seibyl
Minerva Medica|October 18, 2005
The role of neuroimaging in the early diagnosis and evaluation of Parkinson's diseaseJ Seibyl, D Jennings, R Tabamo, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 31, 2012
The molecular basis of dopaminergic brain imaging in Parkinson's diseaseJ Seibyl, D Russell, D Jennings, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 13, 2005
Unique roles of SPET brain imaging in clinical and research studies. Lessons from Parkinson's disease researchJ Seibyl, D Jennings, R Tabamo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 29, 2008
Comparison of noninvasive quantification methods of in vivo vesicular acetylcholine transporter using [123I]-IBVM SPECT imagingO Barret, J Mazère, J Seibyl, et al.
Parkinsonism & Related Disorders|August 13, 2010
FMR1 gene expansion and scans without evidence of dopaminergic deficits in parkinsonism patientsD A Hall, D Jennings, J Seibyl, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|November 30, 1999
The role of quantitative ictal SPECT analysis in the evaluation of nonepileptic seizuresM V Spanaki, S S Spencer, M Corsi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 13, 1999
Sensitivity and specificity of quantitative difference SPECT analysis in seizure localizationM V Spanaki, S S Spencer, M Corsi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 1998
Significance of nonuniform attenuation correction in quantitative brain SPECT imagingN Rajeevan, I G Zubal, S Q Ramsby, et al.
Neurology|December 12, 2001
[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progressionK Marek, R Innis, C van Dyck, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
European Journal of Neurology|December 5, 2002
Do dopamine agonists or levodopa modify Parkinson's disease progression?K Marek, D Jennings, J Seibyl
Minerva Medica|October 18, 2005
The role of neuroimaging in the early diagnosis and evaluation of Parkinson's diseaseJ Seibyl, D Jennings, R Tabamo, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 31, 2012
The molecular basis of dopaminergic brain imaging in Parkinson's diseaseJ Seibyl, D Russell, D Jennings, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 13, 2005
Unique roles of SPET brain imaging in clinical and research studies. Lessons from Parkinson's disease researchJ Seibyl, D Jennings, R Tabamo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 29, 2008
Comparison of noninvasive quantification methods of in vivo vesicular acetylcholine transporter using [123I]-IBVM SPECT imagingO Barret, J Mazère, J Seibyl, et al.
Parkinsonism & Related Disorders|August 13, 2010
FMR1 gene expansion and scans without evidence of dopaminergic deficits in parkinsonism patientsD A Hall, D Jennings, J Seibyl, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|November 30, 1999
The role of quantitative ictal SPECT analysis in the evaluation of nonepileptic seizuresM V Spanaki, S S Spencer, M Corsi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 13, 1999
Sensitivity and specificity of quantitative difference SPECT analysis in seizure localizationM V Spanaki, S S Spencer, M Corsi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 1998
Significance of nonuniform attenuation correction in quantitative brain SPECT imagingN Rajeevan, I G Zubal, S Q Ramsby, et al.
Neurology|December 12, 2001
[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progressionK Marek, R Innis, C van Dyck, et al.
Pageof 2